Ischemic stroke subtypes in subjects with and without diabetes: data from two hospitals in Mongolia


  • Naranchimeg Gendendagva (1) Department of Neurology, Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia. (2) Stroke Center, State Central Third Hospital, Ulaanbaatar 14240, Mongolia.
  • Yanjmaa Sankhuu (1) Department of Endocrinology, Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia. (2) Department of Diabetes and Endocrinology, First State Central Hospital, Ulaanbaatar 14240, Mongolia.
  • Anar Bayarmunkh Department of Endocrinology, Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia.
  • Byambasuren Dagvajantsan Department of Neurology, Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia.
  • Altaisaikhan Khasag Department of Endocrinology, Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia.
  • Oyuntugs Byambasukh Department of Endocrinology, Mongolian National University of Medical Sciences, Ulaanbaatar 13270, Mongolia.



Diabetes, Stroke, TOAST, Atherosclerosis


According to the World Health Organization report in 2020, the number of stroke deaths in Mongolia has reached 4,401, accounting for 19.84% of the total deaths, ranking as the second leading cause of death in Mongolia. Furthermore, the prevalence of diabetes has been steadily increasing for the last 20 years. In this case-control study (80 diabetic and 160 non-diabetic subjects), we analyzed data from two tertiary stroke centers over the past six months (June-December 2022). Inclusion criteria included patients over 18 years who presented to the emergency department with an acute ischemic stroke (I63 according to ICD 10). We reviewed and compared the data on clinical assessments such as the National Institutes of Health The Stroke Scale (NIHTSS), Glasgow Coma Scale and Modified Rankin Score, laboratory parameters, and TOAST classification of ischemic stroke between diabetic and non-diabetic patients in Mongolia. The mean age was 39.2±15.2, and 33.2% (n = 392) were male. The duration of diabetes in patients ranged from 0 to 23 years, and the median was 5.0. Mean glycated haemoglobin in subjects was 9.75±2.49%, and only 27.5% (n = 22) had HbA1c below 7.5%. Only BMI was significantly different in patients with diabetes compared to patients without diabetes (27.2±4.4 vs. 28.6±5.2). However, for other parameters, no significant difference was observed, but the NIHTSS at discharge was significantly higher in patients with diabetes. According to the TOAST classification, the risk of ischemic stroke caused by microangiopathy (18% vs 33.8%, p=0.142) and macroangiopathy (44.4% vs 57.5%, p=0.192) was 13-15% higher in people with diabetes than in people without diabetes. In regression analysis, patients with diabetes had a six times greater risk of ischemic stroke caused by atherosclerosis than non-diabetic patients. Most subtypes of stroke that occur in people with diabetes are caused by atherosclerosis, both large and small vessels.


Adams, H. Jr., Bendixen, B. H., Kappelle, L. J., Biller, J., Love, B. B., Gordon, D. L., & Marsh, E. (1993). Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke, 24(1), 35–41.

Banks, J. L., & Marotta, C. A. (2007). Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke, 38(3), 1091–1096.

Chimed-Ochir, O., Delgermaa, V., Takahashi, K., Purev, O., Sarankhuu, A., Fujino, Y., Bayarmagnai, N., Dugee, O., Erkhembayar, R., & Lkhagvaa, B. (2022). Mongolia health situation: based on the Global Burden of Disease Study 2019. BMC Public Health, 22(1), 1–14.

GBD 2019 Stroke Collaborators. (2021). Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 20(10), 795-820.

Harris, S., Sungkar, S., Rasyid, A., Kurniawan, M., Mesiano, T., & Hidayat, R. (2018). TOAST subtypes of ischemic stroke and its risk factors: a hospital-based study at Cipto Mangunkusumo Hospital, Indonesia. Stroke Research and Treatment, 2018, 9589831.

Hu, C., Low, A., O'Connor, E., Siriratnam, P., Hair, C., Kraemer, T., & Sahathevan, R. (2022). Diabetes in ischaemic stroke in a regional Australian hospital: uncharted territory. Internal Medicine Journal, 52(4), 574–580.

Jørgensen, H., Nakayama, H., Raaschou, H. O., & Olsen, T. S. (1994). Stroke in patients with diabetes. The Copenhagen Stroke Study. Stroke, 25(10), 1977 1984.

Kissela, B. M., Khoury, J., Kleindorfer, D., Woo, D., Schneider, A., Alwell, K., Miller, R., Ewing, I., Moomaw, C. J., & Szaflarski, J. P. (2005). Epidemiology of ischemic stroke in patients with diabetes: the greater Cincinnati/Northern Kentucky Stroke Study. Diabetes Care, 28(2), 355–359.

Koennecke, H., Belz, W., Berfelde, D., Endres, M., Fitzek, S., Hamilton, F., Kreitsch, P., Mackert, B., Nabavi, D. G., & Nolte, C. H. (2011). Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit. Neurology, 77(10), 965–972.

Laing, S. P., Swerdlow, A. J., Carpenter, L. M., Slater, S. D., Burden, A. C., Botha, J. L., Morris, A. D., Waugh, N. R., Gatling, W., & Gale, E. A. (2003). Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke, 34(2), 418–421.

Lindsay, M. P., Norrving, B., Sacco, R. L., Brainin, M., Hacke, W., Martins, S., Pandian, J., & Feigin, V. (2019). World Stroke Organization (WSO): Global Stroke Fact Sheet 2019. International Journal of Stroke, 14(8), 806–817.

Lithner, F., Asplund, K., Eriksson, S., Hägg, E., Strand, T., & Wester, P. O. (1988). Clinical characteristics in diabetic stroke patients. Diabète & Métabolisme, 14(1), 15–19.

Mahdy, M. E., Ghonimi, N. A., Elserafy, T. S., & Mahmoud, W. (2019). The NIHSS score can predict the outcome of patients with primary intracerebral hemorrhage. The Egyptian Journal of neurology, Psychiatry and Neurosurgery, 55(1), 1–5.

Maida, C. D., Daidone, M., Pacinella, G., Norrito, R. L., Pinto, A., & Tuttolomondo, A. (2022). Diabetes and Ischemic Stroke: An Old and New Relationship an Overview of the Close Interaction between These Diseases. International Journal of Molecular Sciences, 23(4), 2397.

Meyer, B. C., Hemmen, T. M., Jackson, C. M., & Lyden, P. D. (2002). Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity. Stroke, 33(5), 1261–1266.

Mima, Y., Kuwashiro, T., Yasaka, M., Tsurusaki, Y., Nakamura, A., Wakugawa, Y., & Okada, Y. (2016). Impact of metformin on the severity and outcomes of acute ischemic stroke in patients with type 2 diabetes mellitus. Journal of Stroke and Cerebrovascular Diseases, 25(2), 436–446.

Mishra, N. K., Davis, S. M., Kaste, M., Lees, K. R., & VISTA collaboration. (2010). Comparison of outcomes following thrombolytic therapy among patients with prior stroke and diabetes in the Virtual International Stroke Trials Archive (VISTA). Diabetes Care, 33(12), 2531–2537.

Mitsios, J. P., Ekinci, E. I., Mitsios, G. P., Churilov, L., & Thijs, V. (2018). Relationship between glycated hemoglobin and stroke risk: a systematic review and meta‐analysis. Journal of the American Heart Association, 7(11), e007858.

Ntaios, G., Milionis, H., Vemmos, K., Makaritsis, K., Ferrari, J., Strbian, D., Curtze, S., Tatlisumak, T., Michel, P., & Papavasileiou, V. (2016). Small-vessel occlusion versus large-artery atherosclerotic strokes in diabetics: Patient characteristics, outcomes, and predictors of stroke mechanism. European Stroke Journal, 1(2), 108–113.

Simonsen, S. A., West, A. S., Heiberg, A. V., Wolfram, F., Jennum, P. J., & Iversen, H. K. (2022). Is the TOAST Classification Suitable for Use in Personalized Medicine in Ischemic Stroke? Journal of Personalized Medicine, 12(3), 496.

Stegmayr, B., Asplund, K., Kuulasmaa, K., Rajakangas, A., Thorvaldsen, P., & Tuomilehto, J. (1997). Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project. An ecological study of 18 populations. Stroke, 28(7), 1367–1374.

Suvd, J., Gerel, B., Otgooloi, H., Purevsuren, D., Zolzaya, H., Roglic, G., & King, H. (2002). Glucose intolerance and associated factors in Mongolia: Results of a national survey. Diabetic Medicine, 6(19), 502–508.

Teasdale, G., Maas, A., Lecky, F., Manley, G., Stocchetti, N., & Murray, G. (2014). The Glasgow Coma Scale at 40 years: standing the test of time. The Lancet Neurology, 13(8), 844–854.

Tuttolomondo, A., Pinto, A., Salemi, G., Di Raimondo, D., Di Sciacca, R., Fernandez, P., Ragonese, P., Savettieri, G., & Licata, G. (2008). Diabetic and non-diabetic subjects with ischemic stroke: differences, subtype distribution and outcome. Nutrition, Metabolism and Cardiovascular Diseases, 18(2), 152–157.

Tziomalos, K., Spanou, M., Bouziana, S. D., Papadopoulou, M., Giampatzis, V., Kostaki, S., Dourliou, V., Tsopozidi, M., Savopoulos, C., & Hatzitolios, A. I. (2014). Type 2 diabetes is associated with a worse functional outcome of ischemic stroke. World Journal of Diabetes, 5(6), 939.

von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet, 370, 1453–1457.

WHO. (2020, 29 June). Mongolia completes its 4th round of STEPS survey on the prevalence of NCD risk factors.

World Life Expectancy. (2020). Stroke in Mongolia.

Zafar, F., Tariq, W., Shoaib, R., Shah, A., Siddique, M., Zaki, A., & Assad, S. (2018). Frequency of ischemic stroke subtypes based on toast classification at a tertiary care center in Pakistan. Asian Journal of Neurosurgery, 13(04), 984–989.




How to Cite

Gendendagva, N., Sankhuu, Y., Bayarmunkh, A., Dagvajantsan, B., Khasag, A. and Byambasukh, O. (2023) “Ischemic stroke subtypes in subjects with and without diabetes: data from two hospitals in Mongolia”, Neuroscience Research Notes, 6(2), pp. 224.1–224.8. doi: 10.31117/neuroscirn.v6i2.224.



Epidemiological Perspective of Neurological and Neuropsychiatric Disorders